Any current/future new fundraising through debt or equity?

The company expects peak debt to increase to around Rs. 100 crores due to ongoing capital expenditure. Part of the capital work in progress will be funded internally. No specific mention of raising new equity or additional debt beyond the current peak debt estimate. The company aims to manage cash flows, reduce debt, and invest in minor projects like energy recovery, but no major CAPEX or fundraising plans are indicated at this time. Management's current focus is to digest recent investments and optimize capacity utilization before considering further large investments or fundraising.

Any current/future capex/capital investment/strategic investment?

The company has completed a significant CAPEX cycle, including commissioning of new plants at Dahej and upgrades at Roha. Current CAPEX includes debottlenecking, safety, environmental, and regulatory investments, such as a zero liquid discharge system at Roha. Ongoing smaller CAPEX projects include upgrades to fire hydrant systems, effluent treatment, and R&D infrastructure. Total CAPEX has faced a cost escalation of about 25-30% due to inflation and supply chain issues. No major CAPEX expansions are planned in the near term; focus is on digesting and optimizing existing investments. Future in

Future growth expectations in sales/revenue/volumes?

The company aims to grow but does not provide specific forward-looking numbers. New plant commissioning at Dahej is expected to significantly boost sales starting Q2 and beyond. Full capacity utilization of new plants is targeted by the end of FY23, depending on market and logistics. Specialty chemicals segment saw around 10% volume growth in FY22; growth expected from both old and new products. Mature specialty products continue to see growth via new applications and replacing competitors. Volume growth targets for specialty chemicals are uncertain; steady volume growth more likely than rapid

Future growth expectations in earnings/operating earnings/profits/EPS?

The company does not provide explicit forward-looking earnings or EPS guidance. They emphasize digesting recent significant investments, especially the new plant at Dahej, before forecasting growth. Operating earnings are affected by raw material price volatility; they maintain a pass-through mechanism in contracts to manage margins. Specialty chemicals are targeted to grow, but volume growth projections (e.g., 15-20%) are uncertain for mature products. New products are achieving planned high margins (~40% EBIT), but pricing and volume growth are subject to market conditions. The commissioning

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders in quantitative terms. Bimal Goculdas mentions "market visibility" while discussing plant utilization, implying reasonable confidence in sales ramp-up but does not provide specific orderbook figures. The company has significant long-term contracts in specialty chemicals, described as ongoing or perpetual, indicating consistent demand rather than fixed pending orders. New capacity expansions (e.g., Dahej plant) are expected to support increased sales, though full utilization is anticipated gradually.

DMCC Speciality Chemicals LtdQ4 FY22Chemicals & Petrochemicals

DMCC Speciality Chemicals Ltd Q4 FY22 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹294.7P/E: 18.4Market Cap: ₹734 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

The company aims to grow but does not provide specific forward-looking numbers.
New plant commissioning at Dahej is expected to significantly boost sales starting Q2 and beyond.
Full capacity utilization of new plants is targeted by the end of FY23, depending on market and logistics.
Specialty chemicals segment saw around 10% volume growth in FY22; growth expected from both old and new products.
Mature specialty products continue to see growth via new applications and replacing competitors.
Volume growth targets for specialty chemicals are uncertain; steady volume growth more likely than rapid spikes.
New CAPEX expected to double previous operational capacity, but with ramp-up periods.
Export and domestic sales mix expected to expand, with some production dedicated to export markets.
BORON segment down 20-25% from peak but prospects are improving due to raw material availability.
Overall growth is linked to successful integration of new capacities, market acceptance, and stable raw material pricing.

Margin guidance

Category 3

The company does not provide explicit forward-looking earnings or EPS guidance.
They emphasize digesting recent significant investments, especially the new plant at Dahej, before forecasting growth.
Operating earnings are affected by raw material price volatility; they maintain a pass-through mechanism in contracts to manage margins.
Specialty chemicals are targeted to grow, but volume growth projections (e.g., 15-20%) are uncertain for mature products.
New products are achieving planned high margins (~40% EBIT), but pricing and volume growth are subject to market conditions.
The commissioning of new plants is expected to drive revenue and margin improvement, with full utilization anticipated by FY23 end.
The company aims to manage working capital and reduce debt as cash flows improve, with no major CAPEX planned until current expansions are digested.
Overall, cautious optimism about future growth with focus on stability and ramp-up rather than aggressive forward guidance.

See what DMCC Speciality Chemicals Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The company expects peak debt to increase to around Rs. 100 crores due to ongoing capital expenditure.
Part of the capital work in progress will be funded internally.
No specific mention of raising new equity or additional debt beyond the current peak debt estimate.
The company aims to manage cash flows, reduce debt, and invest in minor projects like energy recovery, but no major CAPEX or fundraising plans are indicated at this time.
Management's current focus is to digest recent investments and optimize capacity utilization before considering further large investments or fundraising.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders in quantitative terms.
Bimal Goculdas mentions "market visibility" while discussing plant utilization, implying reasonable confidence in sales ramp-up but does not provide specific orderbook figures.
The company has significant long-term contracts in specialty chemicals, described as ongoing or perpetual, indicating consistent demand rather than fixed pending orders.
New capacity expansions (e.g., Dahej plant) are expected to support increased sales, though full utilization is anticipated gradually.
The company emphasizes customer reliability, contracts with multiple suppliers, and formula-based pricing, but no precise order book size or pending order value is disclosed.

See what DMCC Speciality Chemicals Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

The company has completed a significant CAPEX cycle, including commissioning of new plants at Dahej and upgrades at Roha.
Current CAPEX includes debottlenecking, safety, environmental, and regulatory investments, such as a zero liquid discharge system at Roha.
Ongoing smaller CAPEX projects include upgrades to fire hydrant systems, effluent treatment, and R&D infrastructure.
Total CAPEX has faced a cost escalation of about 25-30% due to inflation and supply chain issues.
No major CAPEX expansions are planned in the near term; focus is on digesting and optimizing existing investments.
Future investments may include energy recovery projects and potential product expansions once current capacity is fully utilized.
Debottlenecking efforts are planned, especially in the boron segment, to improve supply and ramp up business.
R&D expansion planned modestly at Dahej but no major increase at Roha currently.

Track DMCC Speciality Chemicals Ltd — get its next earnings analysis in your feed

How does DMCC Speciality Chemicals Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisDMCC Speciality Chemicals Ltd

Rev 3Mar 3

See where DMCC Speciality Chemicals Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does DMCC Speciality Chemicals Ltd rank in Chemicals & Petrochemicals?

Compare DMCC Speciality Chemicals Ltd against every Chemicals & Petrochemicals company (Q4 FY22) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What DMCC Speciality Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

DMCC Speciality Chemicals Ltd Q4 FY22 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does DMCC Speciality Chemicals Ltd rank in Chemicals & Petrochemicals?

Continue your research

What DMCC Speciality Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season